PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
Conditions: Carcinoma, Non-Small-Cell Lung; Immune-Related Adverse Events Interventions: Drug: PD-1 inhibitor; Drug: Chemotherapy Drugs, Cancer Sponsors: Sungkyunkwan University; Ministry of Food and Drug Safety, Korea Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials